Cargando…
COVID19 associated mucormycosis: A review
Mucormycosis, a rare fungal disease has emerged as a new epidemic in India, during the CoronaVirus Disease 2019 (COVID-19) pandemic. Mucormycosis is caused by the mucormycetes group of molds. Immunocompromised states such as diabetes, chronic steroid use, and patients receiving immunosuppressant dru...
Autores principales: | Palanisamy, Priyadharsini R., Elango, Dhivya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963597/ https://www.ncbi.nlm.nih.gov/pubmed/35360784 http://dx.doi.org/10.4103/jfmpc.jfmpc_1186_21 |
Ejemplares similares
-
Mucormycosis: An opportunistic pathogen during COVID-19
por: Mahalaxmi, Iyer, et al.
Publicado: (2021) -
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
por: García-Carnero, Laura C., et al.
Publicado: (2022) -
COVID-19-Associated Pulmonary Mucormycosis
por: Krishna, Vidya, et al.
Publicado: (2022) -
Stop antibiotic resistance – A roller coaster ride through “antibiotic stewardship,” “prescription auditing” and “AWaRe” assessment tool
por: Palanisamy, Priyadharsini R.
Publicado: (2023) -
COVID-19 associated mucormycosis – An emerging threat
por: Chao, Chien-Ming, et al.
Publicado: (2022)